Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea.
Epidemiol Health
; 44: e2022034, 2022.
Article
in En
| MEDLINE
| ID: mdl-35381167
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Humans
Language:
En
Journal:
Epidemiol Health
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication: